MIA3, the gene responsible for producing the TANGO protein involved in collagen export, has no direct documented pharmacogenetic interactions with specific drugs; however, its crucial role in collagen trafficking could theoretically influence the pharmacodynamics of drugs that treat connective tissue diseases, like fibrosis, by potentially affecting tissue growth or degradation, thereby altering drug responses.